These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9698466)

  • 1. Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers.
    Maxwell GL; Risinger JI; Tong B; Shaw H; Barrett JC; Berchuck A; Futreal PA
    Gynecol Oncol; 1998 Jul; 70(1):13-6. PubMed ID: 9698466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
    Maxwell GL; Risinger JI; Gumbs C; Shaw H; Bentley RC; Barrett JC; Berchuck A; Futreal PA
    Cancer Res; 1998 Jun; 58(12):2500-3. PubMed ID: 9635567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
    Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
    Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
    Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
    Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
    Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
    Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
    Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
    Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
    Tashiro H; Blazes MS; Wu R; Cho KR; Bose S; Wang SI; Li J; Parsons R; Ellenson LH
    Cancer Res; 1997 Sep; 57(18):3935-40. PubMed ID: 9307275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
    Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
    Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mutation and expression of PTEN gene mRNA on tumorigenesis and progression of epithelial ovarian cancer.
    Chen Y; Zheng H; Yang X; Sun L; Xin Y
    Chin Med Sci J; 2004 Mar; 19(1):25-30. PubMed ID: 15104221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
    Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
    Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single mutations of the PTEN gene in recurrent ovarian carcinomas.
    Schöndorf T; Dostal A; Grabmann J; Göhring UJ
    J Soc Gynecol Investig; 2000; 7(5):313-6. PubMed ID: 11035285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.
    Risinger JI; Hayes K; Maxwell GL; Carney ME; Dodge RK; Barrett JC; Berchuck A
    Clin Cancer Res; 1998 Dec; 4(12):3005-10. PubMed ID: 9865913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
    Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
    Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.